Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer (original) (raw)

Cancer Gene Therapy volume 7, pages 177–186 (2000)Cite this article

Abstract

Suicide gene therapy has been studied intensively for the treatment of cancer. A limited antitumoral effect was obtained by intratumoral injection of adenovirus harboring Escherichia coli cytosine deaminase gene (AdCD) in tumor-bearing mice followed by continuous administration of 5-fluorocytosine (5FC). To address the drawbacks of the limited potential for the induction of antitumoral immunity by CD suicide gene therapy, we hypothesized that antigen-presenting cells (APCs) might contribute to the efficient induction of an antitumoral immune response in tumor-bearing mice undergoing suicide gene therapy. We preinjected the mice with murine stem cell factor (SCF)-encoding adenovirus (AdSCF) and murine granulocyte-macrophage colony-stimulating factor (GM-CSF)-encoding adenovirus (AdGM-CSF); after 7 days, the mice were inoculated with CT26 colon adenocarcinoma. AdCD was injected intratumorally into tumor-bearing mice followed by 5FC administration. The results showed that AdSCF/AdGM-CSF treatment could increase the number, surface molecule expression, and function of APCs efficiently. A more significant growth inhibition of established tumors and a prolongation of the survival period were observed in tumor-bearing mice after AdSCF/AdGM-CSF pretreatment in combination with AdCD/5FC therapy when compared with mice treated with AdSCF or AdGM-CSF in combination with AdCD/5FC, or AdCD/5FC alone (P < .01). Cytotoxic T-lymphocyte activity was induced efficiently after the combined therapy, and mRNA of tumor necrosis factor-α, interleukin-4, interferon-γ, and interleukin-2 was present in the tumor mass after combined therapy, suggesting that a more potent antitumoral response was induced by enhanced APCs. Our results demonstrated that AdSCF/AdGM-CSF pretreatment could activate APCs, and that these APCs could present the tumor antigens released from AdCD/5FC-killed tumor cells and activate the antitumoral response of the host, thus increasing the therapeutic efficiency of suicide gene therapy.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Immunology, Second Military Medical University, Shanghai, People's Republic of China
    Xuetao Cao, Xin Huang, Dian Wen Ju, Weiping Zhang & Jianli Wang
  2. Department of Molecular Biotherapy Research, Japanese Foundation of Cancer Research, Tokyo, Japan
    Hirofumi Hamada

Authors

  1. Xuetao Cao
    You can also search for this author inPubMed Google Scholar
  2. Xin Huang
    You can also search for this author inPubMed Google Scholar
  3. Dian Wen Ju
    You can also search for this author inPubMed Google Scholar
  4. Weiping Zhang
    You can also search for this author inPubMed Google Scholar
  5. Hirofumi Hamada
    You can also search for this author inPubMed Google Scholar
  6. Jianli Wang
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toXuetao Cao.

Rights and permissions

About this article

Cite this article

Cao, X., Huang, X., Ju, D. et al. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.Cancer Gene Ther 7, 177–186 (2000). https://doi.org/10.1038/sj.cgt.7700114

Download citation

Keywords

This article is cited by